High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.
Björner K, Chen WN, Gannavarapu VR, Axling F, Gulyas M, Halim MA, Webb DL, Hellström PM. Ups J Med Sci. 2023; 28. Epub 2024 Jan 2.